Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
University of Alabama at Birmingham
University College, London
Jonsson Comprehensive Cancer Center
Thomas Jefferson University
City of Hope Medical Center
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
University of Alabama at Birmingham
Emory University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Canadian Cancer Trials Group
Columbia University
Quadriga Biosciences, Inc.
City of Hope Medical Center
Duke University
Biogen
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Lumos Pharma
Celgene
Acrotech Biopharma Inc.
Abramson Cancer Center at Penn Medicine
Medical College of Wisconsin
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
City of Hope Medical Center
Cancer Research UK
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
University of Washington
Duke University
Abramson Cancer Center at Penn Medicine
Memorial Sloan Kettering Cancer Center
Duke University
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)